DarioHealth (DRIO)
(Delayed Data from NSDQ)
$16.35 USD
-0.92 (-5.33%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $16.41 +0.06 (0.37%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DRIO 16.35 -0.92(-5.33%)
Will DRIO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for DRIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DRIO
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
DRIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
Other News for DRIO
Bearish Engulfing appears for DRIO after 5.33% move
Slingshot Bullish appears for DRIO after 0.76% move
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
Shooting Star Candlestick appears for DRIO after 0.98% move
Is DRIO ready to move higher? Pocket Pivot shows up after surging 10.62%